Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 7/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.41 |
| ▸ | PIK3CB | P42338 | 3/20 | 0.41 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | BRD4 | O60885 | 2/20 | 0.41 |
| ▸ | BRD2 | P25440 | 2/20 | 0.41 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | PDE2A | O00408 | 1/20 | 0.41 |
| ▸ | PIK3C2A | O00443 | 1/20 | 0.41 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.41 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.41 |
| ▸ | PDE5A | O76074 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30886452 | 1.00 | PRKDC (0.42) | PRKDCALOX5ALDH1A1PIK3CDPIK3CA | |
| SCHEMBL22182960 | 0.93 | PRKDC (0.43) | PRKDCALOX5ALDH1A1PIK3CDPIK3CA | |
| SCHEMBL15678607 | 0.89 | ALOX5 (0.37) | PRKDCALOX5ALDH1A1PIK3CDPIK3CA | |
| SCHEMBL16441392 | 0.88 | TSHR (0.39) | PRKDCALDH1A1PIK3CDPIK3CAPIK3CB | |
| SCHEMBL15678544 | 0.87 | ALOX5 (0.38) | PRKDCALOX5ALDH1A1PIK3CDPIK3CA | |
| SCHEMBL16441396 | 0.86 | PLAUR (0.39) | PRKDCALDH1A1PIK3CDPIK3CAPIK3CB | |
| SCHEMBL15678586 | 0.84 | MAPT (0.38) | — | |
| SCHEMBL11713826 | 0.84 | PRKDC (0.47) | PRKDCALOX5ALDH1A1PIK3CDPIK3CA | |
| SCHEMBL29396696 | 0.84 | MAPT (0.38) | — | |
| SCHEMBL24665207 | 0.83 | MGLL (0.55) | PRKDCALOX5ALDH1A1PIK3CDPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12428429-B2 | Amine compound and organic light-emitting diode including same | SFC CO., LTD. (KR) | 2025-09-30 | — | — | US | disclosed |
| EP-3654395-B9 | ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY | SFC CO LTD (KR) | 2024-11-06 | — | — | EP | disclosed |
| EP-3654395-B1 | ORGANIC LIGHT EMITTING DIODE HAVING HIGH EFFICIENCY | SFC CO LTD (KR) | 2024-08-28 | — | — | EP | disclosed |
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | P&H TECH CO., LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| CN-118084946-A | Light emitting device and condensed polycyclic compound for light emitting device | 三星显示有限公司 | 2024-05-28 | — | — | CN | disclosed |
| EP-4329431-A2 | NOVEL HETEROLEPTIC IRIDIUM COMPLEXES | Universal Display Corporation (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4329431-A2 | NOVEL HETEROLEPTIC IRIDIUM COMPLEXES | Universal Display Corporation (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-3971197-B1 | NOVEL HETEROLEPTIC IRIDIUM COMPLEXES | UNIVERSAL DISPLAY CORP (US) | 2024-01-03 | — | — | EP | disclosed |
| US-11858952-B2 | Compound and color conversion film comprising same | LG CHEM, LTD. (KR) | 2024-01-02 | — | — | US | disclosed |
| WO-2023234603-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | (주)피엔에이치테크 | 2023-12-07 | — | — | WO | disclosed |
| US-9193745-B2 | Heteroleptic iridium complex | UNIVERSAL DISPLAY CORPORATION (US) | 2015-11-24 | — | — | US | disclosed |
| US-9193745-B2 | Heteroleptic iridium complex | UNIVERSAL DISPLAY CORPORATION (US) | 2015-11-24 | — | — | US | disclosed |
| EP-2857409-A1 | Novel Heteroleptic Iridium Complexes | Universal Display Corporation (US) | 2015-04-08 | — | — | EP | disclosed |
| EP-2857409-A1 | Novel Heteroleptic Iridium Complexes | Universal Display Corporation (US) | 2015-04-08 | — | — | EP | disclosed |
| EP-2594573-B1 | Novel heteroleptic iridium complexes | UNIVERSAL DISPLAY CORP (US) | 2014-12-24 | — | — | EP | disclosed |
| EP-2594573-B1 | Novel heteroleptic iridium complexes | UNIVERSAL DISPLAY CORP (US) | 2014-12-24 | — | — | EP | disclosed |
| EP-2594573-A1 | Novel heteroleptic iridium complexes | Universal Display Corporation (US) | 2013-05-22 | — | — | EP | disclosed |
| US-20130119354-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130119354-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130119354-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | OR10J3, ORMDL3, OR51E2 | PRKDC 4411/4885ALOX5 617/4885ALDH1A1 249/4885 |
| US-12428429-B2 | Amine compound and organic light-emitting diode including same | MAOA, AOC2, MAOB | PRKDC 4570/4885ALOX5 137/4885ALDH1A1 93/4885 |
| US-11858952-B2 | Compound and color conversion film comprising same | BLVRB, CDYL, CRY1 | PRKDC 4285/4885ALOX5 1651/4885ALDH1A1 689/4885 |
| US-20130119354-A1 | HETEROLEPTIC IRIDIUM COMPLEX | OCIAD1, OCIAD2, JUND | PRKDC 1083/4885ALOX5 220/4885ALDH1A1 3244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.